Evaluation of Lumboperitoneal Versus Ventriculoperitoneal Shunts in LM Hydrocephalus

Overview

This study retrospectively compared lumboperitoneal (LP) and ventriculoperitoneal (VP) shunt surgeries for managing communicating hydrocephalus caused by leptomeningeal metastasis (LM) in non-small cell lung cancer (NSCLC) patients. LP shunts, a less invasive alternative, showed potential advantages over VP shunts in safety and feasibility, especially for patients unsuitable for general anesthesia.

Background

Leptomeningeal metastasis (LM) is a severe complication of advanced cancers, notably NSCLC, characterized by malignant spread to the meninges and often resulting in hydrocephalus due to cerebrospinal fluid (CSF) flow obstruction. LM-associated hydrocephalus manifests with neurological symptoms from increased intracranial pressure and requires intervention to improve quality of life. Ventriculoperitoneal (VP) shunting is a standard treatment, but lumboperitoneal (LP) shunting has emerged as a less invasive alternative, potentially reducing surgical risks and anesthesia requirements. Comparative data between these two approaches remain limited, necessitating studies to guide optimal management.

Data Highlights

Key Findings

• LP shunt surgery is a viable alternative to VP shunting for communicating hydrocephalus in LM patients with NSCLC.
• LP shunts offer advantages including less invasiveness and the possibility of avoiding general anesthesia.
• VP shunts require general anesthesia and involve brain catheter insertion, which may increase complication risks.
• Patient selection excluded obstructive hydrocephalus and those with neurological deficits unrelated to hydrocephalus.
• LM diagnosis and classification followed rigorous EANO-ESMO 2023 criteria, ensuring homogeneity in patient cohorts.

Clinical Implications

For NSCLC patients with LM-associated communicating hydrocephalus, LP shunt surgery may provide a safer and less invasive treatment option, particularly for those with poor general condition or contraindications to general anesthesia. Careful patient selection and adherence to diagnostic criteria are essential to optimize outcomes. These findings support considering LP shunts as a first-line surgical intervention in appropriate cases.

Conclusion

LP shunt surgery represents a promising alternative to VP shunting in managing LM-associated communicating hydrocephalus in NSCLC patients, potentially improving safety and feasibility. Further prospective studies are warranted to confirm these findings and refine treatment guidelines.

References

1. EANO-ESMO Guidelines 2023 -- Diagnosis and Classification of Leptomeningeal Metastasis
2. Kyungpook National University Chilgok Hospital Study 2017-2024 -- Comparative Analysis of LP and VP Shunts
3. Literature on LM and Hydrocephalus -- Clinical Features and Treatment Options